Skip Navigation


Clinical Molecular Imaging

Recent technical advances have resulted in the combination of SPECT and PET scanners together with X-ray computed tomography (CT) in a single camera system. These hybrid systems yield maximal information and a complete set of pictures within a single noninvasive imaging study, by integrating molecular information from nuclear imaging with morphologic information from CT. Combined with approved radiopharmaceuticals these technologies allow clinical translation of quantitative molecular imaging of the brain.

Quantitative molecular brain imaging at the highest possible standard is thus available for the workup of suspected or known diseases of the brain such as dementia, epilepsy, tumor and Parkinsonism.

back to top button